Board Meeting20 Oct 2026, 07:10 pm
Aptus Pharma Board Approves Unaudited Financial Results for H1 FY27
AI Summary
Aptus Pharma Ltd announced that its Board of Directors, in a meeting held on October 20, 2026, approved the unaudited financial results for the half-year ended September 30, 2026. The company also informed that the trading window for designated persons will reopen on October 23, 2026. The statutory auditors have issued a limited review report on the financial results.
Key Highlights
- Board approved unaudited financial results for H1 FY27.
- Limited review report from statutory auditors received.
- Trading window to reopen on October 23, 2026.
- Board meeting held on October 20, 2026.
Price Impact
More from APPL